Molecular profiling using tissue microarrays as a tool to identify predictive biomarkers in laryngeal cancer treated with radiotherapy

Cancer Genomics and Proteomics

Volumn 7, Issue 1, 2010, Pages 1-7

  Holgersson, Georg ^a   Ekman, Simon ^a   Reizenstein, Johan ^b   Bergqvist, Michael ^a   Pontén, Fredrik ^e   Uhlén, Mattias ^f   Magnusson, Kristina ^e   Jonnalagadda, Pallavi ^h   Asplund, Anna ^e   Strömberg, Sara ^e   Linder, Arne ^a   Blomquist, Erik ^a   Liljeholm, Martin ^a   Löden, Britta ^d   Hellström, Karin ^g   Bergström, Stefan ^c  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^c Central Hospital   (Sweden)

^d CENTRAL HOSPITAL   (Sweden)

^e UPPSALA UNIVERSITY   (Sweden)

^f ALBANOVA UNIVERSITY CENTER   (Sweden)

^g Regional Oncologic Center   (Sweden)

^h Lab Surgpath   (India)

Author keywords

Cyclin D1; Immunohistochemistry; Ki 67; Laryngeal carcinoma; MSH2; p53; Profiling; Tissue microarray

Indexed keywords

CYCLIN D1; KI 67 ANTIGEN; PROTEIN BCL 2; PROTEIN MSH2; PROTEIN P53;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER CELL; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER RELAPSE; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARYNX CANCER; MALE; MOLECULAR TYPING; PROGNOSIS; PROTEIN EXPRESSION; RADIATION DOSE; SQUAMOUS CELL CARCINOMA; SWEDEN; TISSUE MICROARRAY; TREATMENT OUTCOME;

EID: 77949625967     PISSN: 11096535     EISSN: 17906245     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108, 2005.
2. Black RJ, Bray F, Ferlay J and Parkin DM: Cancer incidence and mortality in the European Union: cancer registry data and estimates of national incidence for 1990. Eur J Cancer 33: 1075-1107, 1997.
3. Abbasi R, Ramroth H, Becher H, Dietz A, Schmezer P and Popanda O: Laryngeal cancer risk associated with smoking and alcohol consumption is modified by genetic polymorphisms in ERCC5, ERCC6 and RAD23B but not by polymorphisms in five other nucleotide excision repair genes. Int J Cancer 125: 1431-1439, 2009.
4. Talamini R, Bosetti C, La Vecchia C, Dal Maso L, Levi F, Bidoli E, Negri E, Pasche C, Vaccarella S, Barzan L and Franceschi S: Combined effect of tobacco and alcohol on laryngeal cancer risk: a case-control study. Cancer Causes Control 13: 957-964, 2002.
5. Spector JG, Sessions DG, Chao KS, Haughey BH, Hanson JM, Simpson JR and Perez CA: Stage I (T1 N0 M0) squamous cell carcinoma of the laryngeal glottis: therapeutic results and voice preservation. Head Neck 21: 707-717, 1999.
6. Spector JG, Sessions DG, Chao KS, Hanson JM, Simpson JR and Perez CA: Management of stage II (T2N0M0) glottic carcinoma by radiotherapy and conservation surgery. Head Neck 21: 116-123, 1999.
7. Spector GJ, Sessions DG, Lenox J, Newland D, Simpson J and Haughey BH: Management of stage IV glottic carcinoma: therapeutic outcomes. Laryngoscope 114: 1438-1446, 2004.
8. Harwood AR, Beale FA, Cummings BJ, Keane TJ and Rider WD: T2 glottic cancer: an analysis of dose-time-volume factors. Int J Radiat Oncol Biol Phys 7: 1501-1505, 1981.
9. Terhaard CH, Snippe K, Ravasz LA, van der Tweel I and Hordijk GJ: Radiotherapy in T1 laryngeal cancer: prognostic factors for locoregional control and survival, uni- and multivariate analysis. Int J Radiat Oncol Biol Phys 21: 1179-1186, 1991.
10. Andersson AC, Stromberg S, Backvall H, Kampf C, Uhlen M, Wester K and Ponten F: Analysis of protein expression in cell microarrays: a tool for antibody-based proteomics. J Histochem Cytochem 54: 1413-1423, 2006.
11. Uhlen M, Bjorling E, Agaton C, Szigyarto CA, Amini B, Andersen E, Andersson AC, Angelidou P, Asplund A, Asplund C, Berglund L, Bergstrom K, Brumer H, Cerjan D, Ekstrom M, Elobeid A, Eriksson C, Fagerberg L, Falk R, Fall J, Forsberg M, Bjorklund MG, Gumbel K, Halimi A, Hallin I, Hamsten C, Hansson M, Hedhammar M, Hercules G, Kampf C, Larsson K, Lindskog M, Lodewyckx W, Lund J, Lundeberg J, Magnusson K, Malm E, Nilsson P, Odling J, Oksvold P, Olsson I, Oster E, Ottosson J, Paavilainen L, Persson A, Rimini R, Rockberg J, Runeson M, Sivertsson A, Skollermo A, Steen J, Stenvall M, Sterky F, Stromberg S, Sundberg M, Tegel H, Tourle S, Wahlund E, Waiden A, Wan J, Wernerus H, Westberg J, Wester K, Wrethagen U, Xu LL, Hober S and Ponten F: A human protein atlas for normal and cancer tissues based on antibody proteomics. Mol Cell Proteomics 4: 1920-1932, 2005.
12. Bjorling E, Lindskog C, Oksvold P, Linne J, Kampf C, Hober S, Uhlen M and Ponten F: A web-based tool for in silico biomarker discovery based on tissue-specific protein profiles in normal and cancer tissues. Mol Cell Proteomics 7: 825-844, 2008.
13. 1 cell-cycle inhibitors in early laryngeal cancer. Am J Otolaryngol 26: 77-82, 2005.
14. Pai HH, Rochon L, Clark B, Black M and Shenouda G: Overexpression of p53 protein does not predict local-regional control or survival in patients with early-stage squamous cell carcinoma of the glottic larynx treated with radiotherapy. Int J Radiat Oncol Biol Phys 41: 37-42, 1998.
15. Friedman M, Lim JW, M anders E, Schaffner AD, Kirshenbaum GL, Tanyeri HM, Caldarelli DD and Coon JS: Prognostic significance of Bcl-2 and p53 expression in advanced laryngeal squamous cell carcinoma. Head Neck 23: 280-285, 2001.
16. Allegra E, Puzzo L, Cutrona D, Trichini A, Garozzo A and Serra A: p53 overexpression on the resection margins as a marker of local recurrence in glottic T1a carcinoma. Acta Otorhinolaryngol Ital 23: 454-458, 2003.
17. Narayana A, Vaughan AT, Kathuria S, Fisher SG, Walter SA and Reddy SP: P53 overexpression is associated with bulky tumor and poor local control in T1 glottic cancer. Int J Radiat Oncol Biol Phys 46: 21-26, 2000.
18. Calli C, Calli A, Pinar E, Oncel S and Demirtasoglu F: [Expression of Ki-67 and p53 in laryngeal squamous cell carcinomas]. Kulak Burun Bogaz Ihtis Derg 15: 9-13, 2005.
19. Deng G, Yang C and Chen W: [The expression of ki-67, topoIIalpha in laryngeal squamous cell carcinoma]. Lin Chuang Er Bi Yan Hou Ke Za Zhi 19: 396-398, 2005.
20. Pastuszewski W, Dziegiel P, Krecicki T, Podhorska-Okolow M, Ciesielska U, Gorzynska E and Zabel M: Prognostic significance of metallothionein, p53 protein and Ki-67 antigen expression in laryngeal cancer. Anticancer Res 27: 335-342, 2007.
21. Acikalin MF, Oner U, Tel N, Pasaoglu O, Cakli H and Colak E: Prognostic significance of Ki-67 expression for patients with laryngeal squamous cell carcinoma primarily treated by total laryngectomy. Eur Arch Otorhinolaryngol 261: 376-380, 2004.
22. Saarilahti K, Kajanti M, Kouri M, Aaltonen LM, Franssila K and Joensuu H: Cyclin A and Ki-67 expression as predictors for locoregional recurrence and outcome in laryngeal cancer patients treated with surgery and postoperative radiotherapy. Int J Radiat Oncol Biol Phys 57: 986-995, 2003.
23. Fracchiolla NS, Capaccio P, Carboni N, Pagliari AV, Neri A, Ronchett D, Pruner G, Silvotti MG, Pignataro L, Buffa R and Broich G: Immunohistochemical and molecular analysis of BAX, BCL2 and P53 genes in laryngeal squamous cell carcinomas. Anticancer Res 19: 1043-1051, 1999.
24. Redondo M, Esteban F, Gonzalez-Moles MA, Delgado-Rodriguez M, Nevado M, Torres-Munoz JE, Tellez T, Villar E, Morell M and Petito CK: Expression of the antiapoptotic proteins clusterin and bcl-2 in laryngeal squamous cell carcinomas. Tumour Biol 27: 195-200, 2006.
25. Vlachtsis K, Nikolaou A, Markou K, Fountzilas G and Daniilidis I: Clinical and molecular prognostic factors in operable laryngeal cancer. Eur Arch Otorhinolaryngol 262: 890-898, 2005.
26. Eriksen JG, Steiniche T and Overgaard J: The role of epidermal growth factor receptor and E-cadherin for the outcome of reduction in the overall treatment time of radiotherapy of supraglottic larynx squamous cell carcinoma. Acta Oncol 44: 50-58, 2005.
27. Gomatos IP, Georgiou A, Giotakis J, Manolopoulos L, Apostolou K, Chatzigianni E, Albanopoulos K and Ferekidou E: The role of host immune response and apoptosis in patients with laryngeal squamous cell carcinoma. ORL J Otorhinolaryngol Relat Spec 69: 159-166, 2007.
28. Yildirim S, Cermik H, Isitmangil T, Baloglu H, Gungor A and Pekkafali Z: Significance of p53 and bcl-2 immunoexpression in the prognosis of laryngeal squamous cell carcinoma. J Int Med Res 30: 597-600, 2002.
29. Dong Y, Sui L, Sugimoto K, Tai Y and Tokuda M: Cyclin D1-CDK4 complex, a possible critical factor for cell proliferation and prognosis in laryngeal squamous cell carcinomas. Int J Cancer 95: 209-215, 2001.
30. Pignataro L, Pruneri G, Carboni N, Capaccio P, Cesana BM, Neri A and Buffa R: Clinical relevance of cyclin D1 protein overexpression in laryngeal squamous cell carcinoma. J Clin Oncol 16: 3069-3077, 1998.
31. Morshed K, Skomra D, Korobowicz E, Szymanski M, Polz-Dacewicz M and Golabek W: An immunohistochemical study of cyclin D1 protein expression in laryngeal squamous cell carcinoma. Acta Otolaryngol 127: 760-769, 2007.
32. Arisi E, Pruneri G, Carboni N, Sambataro G and Pignataro L: Prognostic significance of P27 and cyclin D1 co-expression in laryngeal squamous cell carcinoma: possible target for novel therapeutic strategies. J Chemother 16(Suppl 5): 3-6, 2004.
33. Yoo SS, Carter D, Turner BC, Sasaki CT, Son YH, Wilson LD, Glazer PM and Haffty BG: Prognostic significance of cyclin D1 protein levels in early-stage larynx cancer treated with primary radiation. Int J Cancer 90: 22-28, 2000.
34. Segas JV, Lazaris AC, Nikolopoulos TP, Kavantzas NG, Lendari IE, Tzagkaroulakis AM, Patsouris ES and Ferekidis EA: Cyclin D1 protein tissue detection in laryngeal cancer. ORL J Otorhinolaryngol Relat Spec 67: 319-325, 2005.
35. Vielba R, Bilbao J, Ispizua A, Zabalza I, Alfaro J, Rezola R, Moreno E, Elorriaga J, Alonso I, Baroja A and de la Hoz C: p53 and cyclin D1 as prognostic factors in squamous cell carcinoma of the larynx. Laryngoscope 113: 167-172, 2003.
36. Jiricny J: Replication errors: cha(lle)nging the genome. EMBO J 17: 6427-6436, 1998.
37. Eshleman JR and Markowitz SD: Mismatch repair defects in human carcinogenesis. Hum Mol Genet J Spec No: 1489-1494, 1996.
38. Leach FS, Nicolaides NC, Papadopoulos N, Liu B, Jen J, Parsons R, Peltomaki P, Sistonen P, Aaltonen LA, Nystrom-Lahti M and et al: Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell 75: 1215-1225, 1993.
39. Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S, Torhorst J, Mihatsch MJ, Sauter G and Kallioniemi OP: Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 4: 844-847, 1998.
40. Voduc D, Kenney C and Nielsen TO: Tissue microarrays in clinical oncology. Semin Radiat Oncol 18: 89-97, 2008.